Update on vedolizumab in IBD: What have we learned?

Описание к видео Update on vedolizumab in IBD: What have we learned?

Earn CME for related activities: https://hmpeducation.com/

New findings, new techniques, and recent efforts in research and discovery have changed the way physicians treat their patients – taking a more individualized approach. Mastering Clinical Challenges and Emerging Therapies in IBD, held in Chicago, Illinois on July 23, 2016 provided important clinical updates in the management of patients with inflammatory bowel disease.

In this presentation, Dr. David T. Rubin presents an update on the use of vedolizumab for inflammatory bowel disease (IBD).

Комментарии

Информация по комментариям в разработке